13-49483555-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001160308.3(SETDB2):c.1474A>G(p.Lys492Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000156 in 1,282,968 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001160308.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SETDB2 | NM_001160308.3 | c.1474A>G | p.Lys492Glu | missense_variant | 10/14 | ENST00000611815.2 | |
SETDB2-PHF11 | NR_135324.2 | n.2565A>G | non_coding_transcript_exon_variant | 11/21 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SETDB2 | ENST00000611815.2 | c.1474A>G | p.Lys492Glu | missense_variant | 10/14 | 5 | NM_001160308.3 | P1 | |
SETDB2 | ENST00000354234.8 | c.1510A>G | p.Lys504Glu | missense_variant | 11/15 | 1 | |||
SETDB2 | ENST00000317257.12 | c.1474A>G | p.Lys492Glu | missense_variant | 9/13 | 1 | P1 |
Frequencies
GnomAD3 genomes ? Cov.: 31
GnomAD3 exomes AF: 0.0000222 AC: 4AN: 179834Hom.: 0 AF XY: 0.0000101 AC XY: 1AN XY: 99332
GnomAD4 exome AF: 0.0000156 AC: 20AN: 1282968Hom.: 0 Cov.: 20 AF XY: 0.0000203 AC XY: 13AN XY: 641034
GnomAD4 genome ? Cov.: 31
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 14, 2023 | The c.1510A>G (p.K504E) alteration is located in exon 11 (coding exon 10) of the SETDB2 gene. This alteration results from a A to G substitution at nucleotide position 1510, causing the lysine (K) at amino acid position 504 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at